Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. May 14, 2014; 20(18): 5331-5344
Published online May 14, 2014. doi: 10.3748/wjg.v20.i18.5331
Published online May 14, 2014. doi: 10.3748/wjg.v20.i18.5331
Table 1 Indications and contraindications for liver transplantation in malignancy
Standard indications |
HCC in cirrhosis within Milan criteria |
FLC |
Hepatoblastoma (pediatric patients) |
Epithelioid hemangioendothelioma |
Investigational indications |
HCC in cirrhosis exceeding Milan criteria |
HCC without cirrhosis |
CCA |
Neuroendocrine liver metastases |
Contraindications |
HCC with extrahepatic disease or macro-invasion into portal vein |
Hepatoblastoma with uncontrolled extrahepatic disease |
Malignancies other than the indications mentioned |
Cancer Survivors with complete remission < 2-5 yr[153] |
- Citation: Hackl C, Schlitt HJ, Kirchner GI, Knoppke B, Loss M. Liver transplantation for malignancy: Current treatment strategies and future perspectives. World J Gastroenterol 2014; 20(18): 5331-5344
- URL: https://www.wjgnet.com/1007-9327/full/v20/i18/5331.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i18.5331